All
FDA Reopens Comment Period on Biological Products Development Workshop
FDA's $1.9 Billion Budget Proposal Banks on User Fee Revenues
Correcting the Course
Steer small.
February 2005
Pharmaceutical Science & Technology News
Good Work and True: USP Prepares for Convention 2005
The USP prepares for its quinquennial conference in March.
MHRA to Reinspect Chiron Flu Vaccine Plant
The Pipeline Crisis
Committees make prudent decisions and avoid mistakes, but they're afraid of the new.
January 2005
December 2004
Pharmaco-Fakery
On the other hand, if we don't keep up the pressure on counterfeiting in the US, we may share the plight of the developing world, where nearly 25% of all drugs sold are fakes.
Admix
Still Waiting for Answers
Amid the finger-pointing, hand-wringing, and bloviating, the supply of hard, technical information remains frustratingly small.
November 2004
ITF-Levoxyl
Pharmaceutical science and technology news
October 2004
The High Price of Success
Beyond the inevitable debate over profit margins, the increasing range and effectiveness of modern medicine leave us with one core issue: the high price of success.
USP General Notices and General Test Chapters: Interpretations and Misinterpretations
The authors dispel common misinterpretations of the United States Pharmacopeia.
September 2004
August 2004
July 2004
June 2004
USP's Semi-Hemiquinquennial Meeting
A recent USP gathering generated creative suggestions for the March 2005 USP convocation.
Multicompartment Capsules Prove Less Is More
pharmaceutical science and technology news
May 2004
April 2004
March 2003
January 2004
December 2003
